JPH05932A - Agent for artificial suntan - Google Patents
Agent for artificial suntanInfo
- Publication number
- JPH05932A JPH05932A JP15450591A JP15450591A JPH05932A JP H05932 A JPH05932 A JP H05932A JP 15450591 A JP15450591 A JP 15450591A JP 15450591 A JP15450591 A JP 15450591A JP H05932 A JPH05932 A JP H05932A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- suntan
- effect
- hydroquinone
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】この発明は、日光や紫外線の照射
を受けることなく、皮膚の色を所謂「日焼け色」にする日
焼け剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tanning agent which changes the color of the skin so-called "tan color" without being exposed to sunlight or ultraviolet rays.
【0002】[0002]
【従来の技術】日光浴等によって皮膚を小麦色に焼くこ
とは、健康的イメージを伴うファッション要因として、
特に若い世代の人々を中心に人気があるが、過度の紫外
線照射によって皮膚の炎症だけでなく、肝斑や雀斑を発
生させるという問題がある。2. Description of the Related Art Burning the skin to a brown color by sunbathing or the like is one of the fashion factors accompanied by a healthy image.
It is especially popular among the younger generation, but there is a problem that excessive ultraviolet irradiation causes not only skin inflammation but also liver spots and freckles.
【0003】このような問題の解決策として、日光の暴
露と無関係に皮膚に日焼け色を付与する皮膚着色剤が提
供されている(特開昭62−270512号公報参照)。
しかしながら、この場合には、ヒドロキシアセトンから
誘導される中間生成物と皮膚の淡白成分との皮膚染色反
応を利用するために連続的に使用した後では、皮膚の角
質化の程度によって異なった色合が発現するだけでな
く、洗浄等によって色調が不規則的に消失するという難
点があり、日焼け剤としては十分なものではない。As a solution to such a problem, a skin colorant has been provided which imparts a tan color to the skin irrespective of exposure to sunlight (see JP-A-62-270512).
However, in this case, after continuous use in order to utilize the skin-staining reaction between the intermediate product derived from hydroxyacetone and the skin lightening component, different shades are obtained depending on the degree of keratinization of the skin. Not only is it developed, but there is also the drawback that the color tone disappears irregularly due to washing, etc., and it is not sufficient as a sunburn agent.
【0004】[0004]
【発明が解決しようとする課題】この発明は、このよう
な問題点を解決し、洗浄等によって色調が不規則的に消
失しない日焼け色を、日光や紫外線の照射を受けること
なく、皮膚に均一に発現させる日焼け剤を提供するため
になされたものである。DISCLOSURE OF THE INVENTION The present invention solves the above problems, and evens out a tan color whose color tone does not disappear irregularly by washing or the like on the skin without being exposed to sunlight or ultraviolet rays. It was made in order to provide a tanning agent to be expressed in.
【0005】[0005]
【課題を解決するための手段】即ちこの発明は、ハイド
ロキノン−O−α−D−グルコピラノシドを有効成分と
する日焼け剤に関する。That is, the present invention relates to a tanning agent containing hydroquinone-O-α-D-glucopyranoside as an active ingredient.
【0006】ハイドロキノン−O−D−グルコピラノシ
ド(アルブチン)にはα−異性体とβ−異性体があり、こ
れらの異性体は従来の一般的な製法によれば混合物とし
て得られ、高選択率で調製することは困難である。例え
ば、グルコースとハイドロキノンを、DMSO中、p−
トルエンスルホン酸等の酸触媒の存在下において反応さ
せる方法によっては、α−異性体とβ−異性体は75:
25の割合で得られる(ケミストリー・レターズ(Chemi
stry Letters)、1983年、第1487頁〜第14
88頁参照)。Hydroquinone-O-D-glucopyranoside (arbutin) has α-isomers and β-isomers, and these isomers are obtained as a mixture according to a conventional general production method and are highly selective. It is difficult to prepare. For example, glucose and hydroquinone were added to DMSO in p-
Depending on the method of reacting in the presence of an acid catalyst such as toluenesulfonic acid, the α-isomer and the β-isomer are 75:
Obtained in a ratio of 25 (Chemistry Letters (Chemi Letters)
stry Letters), 1983, pp. 1487-14.
(See page 88).
【0007】これらの異性体のうち、β−異性体は、メ
ラニン色素を生成させる酸化酵素チロシナーゼの活性を
抑制することによって、顕著な皮膚美白効果を発揮する
ことが知られている(特開昭60−56912号公報参
照)。Among these isomers, the β-isomer is known to exert a remarkable skin whitening effect by suppressing the activity of the oxidative enzyme tyrosinase which produces a melanin pigment (Japanese Patent Laid-Open Publication No. Sho. 60-56912).
【0008】ところが、本発明者は、驚くべきことに、
ハイドロキノンと澱粉をCGTアーゼおよび燐酸緩衝液
の存在下で反応させることによって、α−異性体が純粋
に得られるだけでなく、該α−異性体が、β−異性体と
は正反対の特性、即ち、メラニン色素を生成させる酸化
酵素チロシナーゼの活性を促進するという特性を有する
ことを究明した。However, the present inventors have surprisingly found that
By reacting hydroquinone with starch in the presence of CGTase and a phosphate buffer, not only is the α-isomer pure, but the α-isomer has the opposite characteristics to the β-isomer, ie , And has the property of promoting the activity of tyrosinase, an oxidase that produces melanin pigment.
【0009】従って、ハイドロキノン−O−α−D−グ
ルコピラノシドを有効成分とする日焼け剤を皮膚に塗布
することによって、チロシナーゼのメラニン色素生成活
性が促進され、皮膚の色が小麦色に変化し、日焼け効果
が得られる。この日焼け効果は、メラニン色素の生成促
進に起因する実際の日光浴等による日焼けの場合と同様
の機構に基づくもので、極めて自然な皮膚変色効果であ
る。しかもこの場合には、実際の日光浴等の場合とは異
なり、高エネルギーの紫外線の照射を必要としないの
で、皮膚の炎症および肝斑や雀斑の過度の発生という副
作用が問題点となることはない。Therefore, by applying a tanning agent containing hydroquinone-O-α-D-glucopyranoside as an active ingredient to the skin, the melanin pigment-forming activity of tyrosinase is promoted, the skin color changes to a wheat color, and sunburn The effect is obtained. This tanning effect is based on the same mechanism as in the case of actual tanning due to the accelerated production of melanin pigment and is a very natural skin discoloration effect. Moreover, in this case, unlike the case of actual sunbathing, since irradiation of high-energy ultraviolet rays is not required, side effects such as skin inflammation and excessive occurrence of liver spots and freckles do not pose a problem. ..
【0010】ハイドロキノン−O−α−D−グルコピラ
ノシドの配合量は剤型等によって左右され、特に限定的
ではないが、通常は0.0001〜30重量%、好まし
くは0.01〜20重量%であり、0.0001重量%
以下の場合には、十分な日焼け効果が得難く、30重量
%以上配合しても日焼け効果の増大は期待できない。The blending amount of hydroquinone-O-α-D-glucopyranoside depends on the dosage form and the like and is not particularly limited, but is usually 0.0001 to 30% by weight, preferably 0.01 to 20% by weight. Yes, 0.0001% by weight
In the following cases, it is difficult to obtain a sufficient tanning effect, and even if it is blended in an amount of 30% by weight or more, an increase in tanning effect cannot be expected.
【0011】本発明による日焼け剤は、常套の皮膚外用
剤配合処方に準拠して調製すればよく、上記有効成分の
ほかに、化粧品や医薬品等に常用されている各種の成
分、例えば、イオン交換水、アルコール、粉状成分、界
面活性剤、保湿性、香料、着色料、紫外線吸収剤、防腐
剤、粘度調整剤等を適宜配合することができる。The tanning agent according to the present invention may be prepared according to a conventional formulation for external preparation for skin, and in addition to the above-mentioned active ingredients, various ingredients commonly used in cosmetics and pharmaceuticals, such as ion exchange. Water, alcohol, powdery components, surfactants, moisturizing properties, fragrances, colorants, ultraviolet absorbers, preservatives, viscosity modifiers and the like can be appropriately added.
【0012】本発明による日焼け剤は剤型は任意に選定
すればよく、特に限定的ではないが、化粧水、クリー
ム、乳液、軟膏、分散液、噴霧液等が例示される。The dosage form of the tanning agent according to the present invention may be arbitrarily selected, and is not particularly limited, and examples thereof include lotion, cream, emulsion, ointment, dispersion liquid, spray liquid and the like.
【0013】[0013]
【実施例】実施例1 ハイドロキノン2.5%(w/v)、澱粉2%(w/v)、燐酸
緩衝液(pH6.5)10mMおよびCGTアーゼ(バシラス
・マセランス起源)100単位/mlから成る反応液50m
lを三角フラスコ(200ml)に入れ、37℃で90時間
反応をおこない、反応混合物にエタノール100mlを添
加して反応を停止させた後、柝出不溶物を遠心分離処理
によって除去した。残留液をロータリーエバポレーター
を用いる減圧濃縮乾燥処理に付した後、残渣を水7mlに
溶解させ、該水溶液を下記の条件下でのカラムクロマト
グラフィー処理に付し、反応生成物を溶離液体積480
〜540mlで溶離させた: カラム:内径2.6cm×長さ91cm 充填剤:バイオゲルp−2(400メッシュ) 溶離液:5%(v/v)エタノール水溶液 得られた画分を、ロータリーエバポレーターを用いて減
圧濃縮乾固させた後、さらに真空乾燥機を用いて乾燥処
理をおこなって、生成物を白色粉末として39mg得た。
該生成物は下記の条件下での薄層クロマトグラフィーに
おいて単一であった(Rf値:0.61): 薄層:シリカゲル60F254 展開溶媒:酢酸エチル/酢酸/水(3:1:1) 検出:紫外線照射または硫酸/メタノール(1:2)混合物
を噴霧後、110〜120℃に加熱して発色させる。【Example】Example 1 Hydroquinone 2.5% (w / v), starch 2% (w / v), phosphoric acid
Buffer (pH 6.5) 10 mM and CGTase (Bacillus
・ Macerans origin) 50m reaction liquid consisting of 100 units / ml
Add l to Erlenmeyer flask (200ml) and keep at 37 ℃ for 90 hours.
Perform the reaction and add 100 ml of ethanol to the reaction mixture.
After adding the reaction to stop the reaction, centrifuge the insoluble matter.
Removed by. Residual liquid is rotary evaporator
After vacuum concentration and drying treatment using
Dissolve the aqueous solution and perform column chromatography under the following conditions.
The reaction product was subjected to a chromatographic treatment and the eluent volume was 480
Elution with ~ 540 ml: column: inner diameter 2.6 cm x length 91 cm packing material: biogel p-2 (400 mesh) eluent: 5% (v / v) aqueous ethanol solution The obtained fractions were filtered on a rotary evaporator. Reduced by
After pressure concentrating to dryness, it is further dried using a vacuum dryer.
Then, 39 mg of the product was obtained as a white powder.
The product was subjected to thin layer chromatography under the following conditions:
(Rf value: 0.61): Thin layer: Silica gel 60F254 Developing solvent: Ethyl acetate / acetic acid / water (3: 1: 1) Detection: UV irradiation or sulfuric acid / methanol (1: 2) blend
After spraying, the color is developed by heating at 110 to 120 ° C.
【0014】該生成物(ハイドロキノン−O−α−D−
グルコピラノシド)の1H−NMR(ppm;CH3OH−d4)
のデータは次の通りである: 3.31(1H,dd)、3.45(1H,t)、3.57(1H,d
d)、3.76(2H,dd,H−6)、3.88(1H,t)、5.
34(1H,d,J=3.7Hz、アノマーH)、6.72(4
H,s,アロマチックH)The product (hydroquinone-O-α-D-
Glucopyranoside) of 1 H-NMR (ppm; CH 3 OH-d 4)
Data are as follows: 3.31 (1H, dd), 3.45 (1H, t), 3.57 (1H, d)
d), 3.76 (2H, dd, H-6), 3.88 (1H, t), 5.
34 (1H, d, J = 3.7Hz, anomer H), 6.72 (4
H, s, aromatic H)
【0015】実施例2 上記実施例1で得られたハイドロキノン−O−α−D−
グルコピラノシドの日焼け効果を以下の方法によって評
価した。日焼け効果の指標としては、メラニン色素を生
成させる酸化酵素チロシナーゼの活性を促進する割合で
表す方法を用いた。 チロシナーゼの活性促進:チロシナーゼの活性促進はL
−ドーパを基質として次に述べる手順で行った。 試料溶液:ハイドロキノン−α−D−グルコピラノシド
の150、300および600mM濃度の水溶液を調製
した。 酵素溶液:チロシナーゼ(シグマ社製)を2000単位/m
lとなるように水に溶解して調製した。 測 定:試料0.05mlに基質溶液0.5mlおよび燐酸
緩衝液(20mM:pH6.5)0.9mlを加え、25℃で5
分間インキュベートする。これにあらかじめ25℃でイ
ンキュベートした酵素溶液0.05mlを加えて1.5分間
反応させ、475nm吸光度を測定した。活性の促進率
は次式によって算出した。 促進率=((T−T')/(C−C')−1)×100(%) T :促進剤を添加した場合の吸光度 T':促進剤を添加し、基質を添加しない場合の吸光度 C :促進剤を添加しない場合の吸光度 C':促進剤も基質も加えない場合の吸光度 得られた結果は次の通りである。[0015]Example 2 The hydroquinone-O-α-D-obtained in Example 1 above
The sunburn effect of glucopyranoside was evaluated by the following method.
I paid. As a measure of the sunburn effect, melanin pigment is produced.
At a rate that promotes the activity of the oxidative enzyme tyrosinase
The method described was used. Promotion of tyrosinase activity: Promotion of tyrosinase activity is L
-Dopa was used as a substrate according to the following procedure. Sample solution: Hydroquinone-α-D-glucopyranoside
Of 150, 300 and 600 mM aqueous solutions
did. Enzyme solution: Tyrosinase (manufactured by Sigma) 2000 units / m
It was prepared by dissolving it in water so as to have a volume of l. Measurement: 0.05 ml sample to 0.5 ml substrate solution and phosphoric acid
Add 0.9 ml of buffer solution (20 mM: pH 6.5) and add 5 ml at 25 ° C.
Incubate for minutes. Add this to 25 ° C beforehand.
Incubate 0.05 ml of enzyme solution for 1.5 minutes
The reaction was carried out and the absorbance at 475 nm was measured. Activity promotion rate
Was calculated by the following formula. Acceleration rate = ((TT ′) / (CC ′) − 1) × 100 (%) T: Absorbance when a promoter is added T ′: When a promoter is added and a substrate is not added Absorbance C: Absorbance without addition of promoter C ': Absorbance without addition of promoter or substrate The results obtained are as follows.
【0016】 [0016]
【0017】[0017]
【発明の効果】本発明による日焼け剤を皮膚に塗布する
ことによって、日光浴等による日焼けの場合と同様に、
極めて自然な小麦色への皮膚変色効果が得られる。しか
もこの場合には、実際の日光浴等の場合と異なり、紫外
線の照射を必要としないので、皮膚の炎症および肝斑や
雀斑の過度の発生という副作用を伴うことなく、健康的
イメージを基調としたファッション志向に応えることが
できる。By applying the tanning agent according to the present invention to the skin, as in the case of tanning by sunbathing, etc.,
An extremely natural color change to the skin is obtained. Moreover, in this case, unlike the case of actual sunbathing, since it does not require the irradiation of ultraviolet rays, it is based on a healthy image without causing side effects such as skin inflammation and excessive occurrence of liver spots and freckles. It can respond to fashion orientation.
Claims (1)
ラノシドを有効成分とする日焼け剤。What is claimed is: 1. A tanning agent comprising hydroquinone-O-α-D-glucopyranoside as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15450591A JPH05932A (en) | 1991-06-26 | 1991-06-26 | Agent for artificial suntan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15450591A JPH05932A (en) | 1991-06-26 | 1991-06-26 | Agent for artificial suntan |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05932A true JPH05932A (en) | 1993-01-08 |
Family
ID=15585713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15450591A Pending JPH05932A (en) | 1991-06-26 | 1991-06-26 | Agent for artificial suntan |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05932A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091715A3 (en) * | 2000-06-02 | 2002-07-04 | Pentapharm Ltd | Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside |
WO2002072039A3 (en) * | 2001-03-09 | 2002-11-28 | Pentapharm Ltd | Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose |
-
1991
- 1991-06-26 JP JP15450591A patent/JPH05932A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091715A3 (en) * | 2000-06-02 | 2002-07-04 | Pentapharm Ltd | Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside |
WO2002072039A3 (en) * | 2001-03-09 | 2002-11-28 | Pentapharm Ltd | Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2502318B2 (en) | Whitening cosmetics | |
WO2004103265A2 (en) | Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same | |
EP1172091B1 (en) | Use of 4',5,7-trihydroxyflavylium for coloring the skin | |
JP2929304B2 (en) | Skin whitening preparation for external use | |
US20110318398A1 (en) | Cosmetic composition comprising molecular encapsulated fermented extract of rhus javanica l. as an active ingredient | |
US6706257B1 (en) | Sunless tanning products and processes | |
JP3695472B2 (en) | Maillard reaction inhibitor | |
JP2008239545A (en) | Elastase deactivator | |
EP1172090B1 (en) | Skin dyeing compositions comprising dihydroxyacetone and a flavylium salt non substituted in position 3 | |
US20040042984A1 (en) | Skin whitening composition containing arbutin and glucosidase as active ingredients | |
JPH0660089B2 (en) | Hair dye cosmetics | |
JPH10273417A (en) | Beautifully whitening agent and beautifully whitening | |
JP3460100B2 (en) | Whitening agent | |
JPH05932A (en) | Agent for artificial suntan | |
EP1575930B1 (en) | Novel retinol derivative and cosmetic composition comprising the same | |
JPH10279428A (en) | Cosmetic | |
JP2004345969A (en) | Tyrosinase inhibitor and bleaching cosmetic using the same | |
JP4726505B2 (en) | External preparation for skin and skin whitening method | |
JP3120086B2 (en) | Hair cosmetics for prevention of gray hair and blackening of gray hair | |
JP3120087B2 (en) | Hair cosmetics for prevention of gray hair and blackening of gray hair | |
JPH10279468A (en) | Skin preparation for external use | |
JPS6078911A (en) | Cosmetic | |
JPH10279462A (en) | Skin preparation for external use | |
JPH10279460A (en) | Skin preparation for external use | |
JP2000290131A (en) | Bleaching preparation |